‘The funding amount provided should be reasonable to meet requirements’
The best scheme for Technology Upgradation Fund Scheme (TUFS) for SMEs should be the one that identifies their need and meets…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
‘Government may consider offering higher depreciation benefits’
Pharma export associations should act as a facilitator in setting up warehouses in Asian, Latin American and African countries by…
‘Urge GoI to take strong steps towards ensuring availability of skilled manpower, electricity,…
SEZ's pain TIL Healthcare has set-up a state-of-the-art facility at an SEZ in 2010 with a focus on export. However, two years down…
The Blockbuster goes bust?
The blockbuster model has so far been the success formula of pharma companies, however, if statistics are to be believed, a churn…
‘Regulatory plays a major role in shaping up the market for infectious disease diagnostics in…
Infectious diseases continue to account for majority of the disease burden in developing countries even as they grapple with an…
Cipla collaborates with Hetero to launch its second biosimilar drug Darbepoetin alfa
Is indicated for the treatment of anaemia caused due to chronic kidney disease
Abbott to acquire Latin American CFR Pharmaceuticals
Abbott will acquire the holding company that indirectly owns approximately 73 per cent of CFR Pharmaceuticals
Merck Serono and Mersana to develop antibody-drug conjugates
Mersana and Merck Serono will leverage Mersana’s Fleximer technology to generate ADCs for multiple undisclosed targets
Arvind Remedies and Adesh University sign MOU
To launch new drugs for treating Type-II diabetes, depression and coronary heart diseases
IPM registers Rs 6636 crores in May 2014
11 therapies have outgrown the IPM growth and five therapies have double digit growths